WORLD Norwegian health authorities say deaths among elderly likely related to vaccine

WORLD

Norwegian health authorities say deaths among elderly likely related to vaccine

Xinhua

15:01, January 16, 2021

COPENHAGEN, Jan. 15 (Xinhua) -- An adverse reaction to the first dose of the COVID-19 vaccine may be responsible for as many as 23 reported deaths among frail and elderly patients in nursing homes in Norway, said a press release from the Norwegian Medicines Agency (NoMA) on Friday.

A patient with coronavirus disease (COVID-19) is treated in the intensive care unit (ICU) at Oslo University Hospital Rikshospitalet, in Oslo, Norway November 27, 2020. [Photo/Agencies]

The studies on Comirnaty (Pfizer-BioNTech) included few participants aged over 85 and did not include patients with unstable or acute illness, according to NoMA.

"The assessment suggests that common adverse reactions to mRNA vaccines, such as fever and nausea, may have contributed to a fatal outcome in some frail patients," said Sigurd Hortemo, NoMA's chief physician.

Reports of suspected adverse reactions including death are received on a daily basis and are continuously assessed by both the Norwegian Medicines Agency and the National Institute of Public Health (NIPH), said the press release.

As a result of 13 autopsies of the deceased undertaken for the assessment, the NIPH has updated the COVID-19 vaccination guidelines, providing more detailed advice on the vaccination of the elderly who are frail.

"Doctors must now carefully consider who should be vaccinated. Those who are very frail and at the very end of life can be vaccinated after an individual assessment," Madsen added.

More than 25,000 Norwegians have been vaccinated against COVID-19 since Dec. 27, 2020.

Related Stories

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue